Bandingkan Harga & Kinerja Sarimelati Kencana Tbk. (PZZA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sarimelati Kencana Tbk. dan Organon Pharma Indonesia Tbk.: Sarimelati Kencana Tbk. diperdagangkan di Rp193 (kapitalisasi pasar 586,24 M, volume 24 jam 522,8 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Sarimelati Kencana Tbk. jauh lebih besar — sekitar 5,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PZZA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 586,24 M | 104,4 M |
Volume | 522,8 rb | — |
Lot | 5,23 rb | — |
Perputaran | 100,6 jt | — |
Harga Rata-rata | 192,43 | — |
Nilai Transaksi | 100,6 jt | — |
Harga Ekuilibrium Indikatif | 193 | — |
Volume Ekuilibrium Indikatif | 474 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sarimelati Kencana Tbk.
PT Sarimelati Kencana Tbk. (the Company) was established based on Notarial Deed No. 132 dated December 16, 1987 of Lieke Lianadevi Tukgali, S.H.
Selengkapnya di halaman PZZA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
